The Clorox Company (NYSE:CLX) Shares Sold by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC lowered its holdings in The Clorox Company (NYSE:CLX) by 31.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,870 shares of the company’s stock after selling 4,158 shares during the period. Kestra Private Wealth Services LLC’s holdings in Clorox were worth $1,265,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Dakota Wealth Management grew its stake in Clorox by 20.0% during the 3rd quarter. Dakota Wealth Management now owns 2,642 shares of the company’s stock worth $346,000 after buying an additional 440 shares during the last quarter. Raymond James & Associates boosted its holdings in shares of Clorox by 8.0% during the third quarter. Raymond James & Associates now owns 306,613 shares of the company’s stock valued at $40,185,000 after acquiring an additional 22,597 shares during the period. Stratos Wealth Advisors LLC grew its position in shares of Clorox by 3.1% during the third quarter. Stratos Wealth Advisors LLC now owns 5,026 shares of the company’s stock worth $659,000 after acquiring an additional 150 shares during the last quarter. Forsta AP Fonden increased its holdings in shares of Clorox by 30.4% in the 3rd quarter. Forsta AP Fonden now owns 37,700 shares of the company’s stock worth $4,941,000 after acquiring an additional 8,800 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Clorox by 3.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 47,639 shares of the company’s stock valued at $6,244,000 after purchasing an additional 1,620 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of CLX opened at $138.23 on Friday. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.57. The firm’s 50 day moving average is $148.74 and its 200-day moving average is $143.08. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $176.24. The stock has a market capitalization of $17.17 billion, a P/E ratio of 71.62, a P/E/G ratio of 2.08 and a beta of 0.44.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the previous year, the business posted $1.51 earnings per share. The firm’s quarterly revenue was down 5.3% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 5.85 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be issued a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a dividend yield of 3.47%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio is 248.70%.

Analyst Ratings Changes

Several research analysts have commented on CLX shares. DA Davidson restated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. Wells Fargo & Company lowered their target price on Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a research report on Thursday. Barclays reduced their price target on Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a research report on Thursday. Deutsche Bank Aktiengesellschaft lowered their price target on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $146.43.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.